,glofitamab

Weiya Wang1, Meiyu Chen1, Jin Li1

  • 1Department of Hematology, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.

Leukemia & lymphoma
|April 2, 2025
PubMed
概括

格洛菲他马布为复发性耐火性中枢神经系统原发性淋巴瘤 (R/R PCNSL) 提供了一种新的治疗选择. 这种疗法在患有R/R PCNSL的患者中实现了完全缓解,对这种具有挑战性的疾病显示出希望.